Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for Venn Biosciences' Dawn Test
Stopped The study recruited no participants due to a pre-recruitment decision by the sponsor to not proceed. Factors considered included logistics, resources, and new research data.
Conditions
- Non Small Cell Lung Cancer
Interventions
- OTHER: Educational Materials on the Dawn test
Sponsor
Qure Healthcare, LLC
Collaborators